|Committee Member||Employment||Consultant||Speaker||Ownership/Partnership/Principal||Research||Institutional, Organizational or Other Financial Benefit||Expert Witness|
|Loren F. Hiratzka, Chair||Cardiac, Vascular & Thoracic Surgeons Inc. and TriHealth Inc.—Medical Director, Cardiac Surgery||None||None||None||None||None|
|George L. Bakris||University of Chicago Medical Center—Professor of Medicine; Director, Hypertension Center||None||None||None|
|Joshua A. Beckman||Brigham & Women's Hospital—Director, Cardiovascular Fellows Program||None||None||None||None|
|Robert M. Bersin||Seattle Cardiology—Director, Endovascular Services & Clinical Research|
|Vincent F. Carr||Uniformed Services University of Health Science—Professor of Medicine||None||None||None||None||None||None|
|Donald E. Casey, Jr||Atlantic Health—Vice President of Quality & Chief Medical Officer; Associate Professor of Medicine, Mount Sinai School of Medicine||None||None||None||None||None||None|
|Kim A. Eagle||University of Michigan Health System—Albion Walter Professor of Internal Medicine; Clinical Director, Cardiovascular Center||None||None||None||None|
|Luke K. Hermann||Mount Sinai Medical Center—Assistant Professor of Emergency Medicine; Director, Chest Pain Unit||None||None||None||None||None||None|
|Eric M. Isselbacher||Massachusetts General Hospital—Associate Professor of Medicine, Harvard Medical School; Co-Director, Thoracic Aortic Center||None||None||None||None||None|
|Ella A. Kazerooni||University of Michigan Health System—Professor of Medicine; Director, Cardiothoracic Radiology||None||None||None||None|
|Nicholas T. Kouchoukos||Missouri Baptist Medical Center—Cardiovascular Surgeon||None||None||None||None|
|Bruce W. Lytle||The Cleveland Clinic—Chair, Heart and Vascular Institute||None||None||None||None||None||None|
|Dianna M. Milewicz||University of Texas Southwestern Medical Center—President George H.W. Bush Chair in Cardiovascular Medicine; Professor & Director, Division of Medical Genetics||None||None||None||None||None|
|David L. Reich||Mount Sinai Medical Center—Professor & Chair, Department of Anesthesiology||None||None||None||None||None||None|
|Souvik Sen||University of South Carolina School of Medicine–Professor and Chair, Department of Neurology||None||None||None|
|Julie A. Shinn||Stanford University School of Medicine—Cardiovascular Clinical Nurse Specialist||None||None||None||None||None||None|
|Lars G. Svensson||The Cleveland Clinic—Director, The Center for Aortic Surgery; Director, Marfan Syndrome and Collective Tissue Disorder Clinic||None||None||None||None||None|
|David M. Williams||University of Michigan Health System—Professor, Department of Radiology; Director, Interventional Radiology||None||None||None|
NHLBI indicates National Heart, Lung, and Blood Institute; NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases.
This table represents the relevant relationships of committee members with industry and other entities that were reported orally at the initial writing committee meeting and updated in conjunction with all meetings and conference calls of the writing committee during the document development process. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity, or ownership of $10 000 or more of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships noted in this table are modest unless otherwise noted.
*Significant (greater than $10 000) relationship.